Possibility of generating lung tissue for transplant using a patient’s own cells
For the first time, scientists have succeeded in transforming human stem cells into functional lung and airway cells. The advance, reported by Columbia University Medical Center (CUMC) researchers, has significant potential for modeling lung disease, screening drugs, studying human lung development, and, ultimately, generating lung tissue for transplantation. The study was published today in the journal Nature Biotechnology.
“Researchers have had relative success in turning human stem cells into heart cells, pancreatic beta cells, intestinal cells, liver cells, and nerve cells, raising all sorts of possibilities for regenerative medicine,” said study leader Hans-Willem Snoeck, MD, PhD, professor of medicine (in microbiology & immunology) and affiliated with the Columbia Center for Translational Immunology and the Columbia Stem Cell Initiative. “Now, we are finally able to make lung and airway cells. This is important because lung transplants have a particularly poor prognosis. Although any clinical application is still many years away, we can begin thinking about making autologous lung transplants—that is, transplants that use a patient’s own skin cells to generate functional lung tissue.”
The research builds on Dr. Snoeck’s 2011 discovery of a set of chemical factors that can turn human embryonic stem (ES) cells or human induced pluripotent stem (iPS) cells into anterior foregut endoderm—precursors of lung and airway cells. (Human iPS cells closely resemble human ES cells but are generated from skin cells, by coaxing them into taking a developmental step backwards. Human iPS cells can then be stimulated to differentiate into specialized cells—offering researchers an alternative to human ES cells.)
In the current study, Dr. Snoeck and his colleagues found new factors that can complete the transformation of human ES or iPS cells into functionawebl lung epithelial cells (cells that cover the lung surface). The resultant cells were found to express markers of at least six types of lung and airway epithelial cells, particularly markers of type 2 alveolar epithelial cells. Type 2 cells are important because they produce surfactant, a substance critical to maintain the lung alveoli, where gas exchange takes place; they also participate in repair of the lung after injury and damage.
The findings have implications for the study of a number of lung diseases, including idiopathic pulmonary fibrosis (IPF), in which type 2 alveolar epithelial cells are thought to play a central role. “No one knows what causes the disease, and there’s no way to treat it,” says Dr. Snoeck. “Using this technology, researchers will finally be able to create laboratory models of IPF, study the disease at the molecular level, and screen drugs for possible treatments or cures.”
“In the longer term, we hope to use this technology to make an autologous lung graft,” Dr. Snoeck said. “This would entail taking a lung from a donor; removing all the lung cells, leaving only the lung scaffold; and seeding the scaffold with new lung cells derived from the patient. In this way, rejection problems could be avoided.” Dr. Snoeck is investigating this approach in collaboration with researchers in the Columbia University Department of Biomedical Engineering.
The Latest on: Human stem cells
- Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Programon May 9, 2024 at 7:20 am
Pre-treatment Sample of Patient’s Blood Showed Rapid and Potent Depletion of CD19+ B Cells in Ex Vivo Cytotoxicity Assay with FT819Translational ...
- How aging clocks tick: New study points to stochastic changes in cellson May 9, 2024 at 7:13 am
Aging clocks can measure the biological age of humans with high precision. Biological age can be influenced by environmental factors such as smoking or diet, thus deviating from chronological age that ...
- As Ozzy Osbourne announces stem cell therapy, experts urge caution, highlight riskson May 9, 2024 at 2:00 am
As rock legend Ozzy Osbourne has turned to stem cell therapy, some experts caution that the treatment is not for everyone. A doctor weighed in on the potential risks.
- Cross-species liver cell growth could represent a solution to transplant shortageon May 8, 2024 at 10:24 pm
Liver disease, due to viral infections, alcohol abuse, obesity, or cancer, accounts for 1 in every 25 deaths worldwide.
- Scientists Discover How the Human Brain Achieves Its Large Sizeon May 8, 2024 at 5:00 pm
A team of molecular biologists from the Austrian Academy of Sciences has now demonstrated that some human neural stem cells can multiply for a much longer period than expected and produce that large ...
- Stem Cell Therapy Improves Post-Stroke Motor Functionon May 7, 2024 at 5:00 pm
CHICAGO — Early results from a first-in-human trial some 20 years in the making suggest that neural stem cell transplantation is safe and improves motor function starting at 1 month after treatment in ...
- Researchers Breed Mice With Hybrid Brains Containing Cells From Ratson May 2, 2024 at 2:00 pm
Next, scientists injected rat stem cells into mouse embryos that had the same smelling ... “This has a great opportunity for human health, where we can understand better how to make cell replacement ...
- Toward Ageless Muscles: The Stem Cell Solutionon May 2, 2024 at 10:45 am
Theoretically, scientists should be able to grow human pluripotent stem cells in the laboratory and “sculpt” them into muscle stem cells, which can go on to develop into full-blown muscle cells.
- Bioreactor processes and cryotechnologies improve active ingredient tests using human cell cultureson May 2, 2024 at 10:40 am
Specially prepared cell cultures made from human tissue known as human induced pluripotent stem (hiPS) cells enable greater reliability in testing, thereby also increasing the chances that a drug will ...
- New and improved way to grow the cells that give rise to the kidney's filtration systemon April 29, 2024 at 5:00 pm
Scientists report significant progress in cultivating nephron progenitor cells (NPCs), the cells destined to form the kidney's filtration system, the nephrons. NPCs hold immense promise for ...
via Bing News
The Latest on: Autologous lung graft
- TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumorson May 9, 2024 at 5:47 am
Patient dosed with TSC-203-A0201 targeting cancer-associated antigen PRAMEOn-track to report initialdata from the solid tumor clinical trialin ...
- Severe complication from lung transplantation has been underestimated, researchers findon May 2, 2024 at 1:53 pm
"However, our detailed analysis of ABO-mismatched transplants revealed that depending on the specific blood group combination between donor and recipient, up to 30 percent of patients developed ...
- Phase 3 Data Show Exa-Cel Prevents Vaso-Occlusive Crises for At Least 1 Year in SCDon May 1, 2024 at 5:00 pm
“Overall, the safety profile of exa-cel was generally consistent with myeloablative busulfan-based conditioning and autologous transplantation ... The patient also had busulfan-associated lung injury ...
- Lung Transplantationon April 20, 2024 at 1:55 am
Špirudová, Lenka and Nol, Jaroslav 2014. Quality of life of patients after lung transplantation. Kontakt, Vol. 16, Issue. 1, p. e9. Novická, Katarina and Jungová ...
- How myeloid cell replacement could help treat autoimmune encephalomyelitison April 18, 2024 at 5:00 pm
"The transplantation of patient-derived autologous hematopoietic cells is currently under investigation as a promising therapy option for treatment-resistant multiple sclerosis," Marius Mader ...
- Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphomaon April 17, 2024 at 5:00 pm
Therapy-related myeloid neoplasm (t-MN) is a life-threatening complication of autologous peripheral blood stem cell transplantation (aPBSCT) for Hodgkin lymphoma (HL). Although previous studies have ...
- Autologous Hematopoietic Stem Cell Transplantation in Autoimmune Diseaseson April 15, 2024 at 5:00 pm
Among rheumatologic ADs, SS is the most common indication, but there is some doubt as to whether the interest in autologous HSCT has been elicited by distinctive features of the disease or by the ...
- COPD Risk is Increased in TB Survivorson April 14, 2024 at 5:00 pm
P63+ Cell Therapy for COPD Early evidence suggests promise for a novel COPD treatment using autologous P63+ lung progenitor cell. This small study found the bronchoscopic transplantation of ...
- Long-term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-transplantation Relapseon April 14, 2024 at 5:00 pm
Background: Autologous stem cell transplantation (autoSCT) has an important role in the treatment of patients with symptomatic multiple myeloma (MM). Treatment options for myeloma have expanded in ...
- Robotic lung transplantation: A paradigm shift in surgical approachon April 11, 2024 at 5:00 pm
While debating the pros and cons of robotically assisted lung transplantation, Albert Jauregui, MD, PhD told attendees at the Annual Meeting and Scientific Sessions of the International Society ...
via Bing News